Transjugular intrahepatic portosystemic shunt for treatment of cirrhosis-related chylothorax and chylous ascites: single-institution retrospective experience

Cardiovasc Intervent Radiol. 2013 Aug;36(4):992-7. doi: 10.1007/s00270-012-0530-x. Epub 2012 Dec 4.

Abstract

Purpose: To investigate the efficacy and safety of the use of transjugular intrahepatic portosystemic shunt (TIPS) creation to treat cirrhosis-related chylous collections (chylothorax and chylous ascites).

Methods: We retrospectively reviewed data from four patients treated for refractory cirrhosis-related chylous collections with TIPS at our institution over an 8 year period.

Results: One patient had chylothorax, and three patients had concomitant chylothorax and chylous ascites. There were no major complications, and the only procedure-related complications occurred in two patients who had mild, treatable hepatic encephalopathy. All patients had improvement as defined by decreased need for thoracentesis or paracentesis, with postprocedure follow-up ranging from 19 to 491 days.

Conclusion: TIPS is a safe procedure that is effective in the treatment of cirrhosis-related chylous collections.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chylothorax / etiology
  • Chylothorax / mortality
  • Chylothorax / physiopathology
  • Chylothorax / surgery*
  • Chylous Ascites / etiology
  • Chylous Ascites / mortality
  • Chylous Ascites / physiopathology
  • Chylous Ascites / surgery*
  • End Stage Liver Disease / complications
  • End Stage Liver Disease / diagnosis
  • End Stage Liver Disease / mortality
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / mortality
  • Male
  • Middle Aged
  • Paracentesis / methods
  • Patient Safety
  • Portasystemic Shunt, Transjugular Intrahepatic / adverse effects
  • Portasystemic Shunt, Transjugular Intrahepatic / methods*
  • Postoperative Complications / mortality
  • Postoperative Complications / physiopathology
  • Retrospective Studies
  • Risk Assessment
  • Sampling Studies
  • Severity of Illness Index
  • Survival Rate
  • Treatment Outcome